Apr 24 |
Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying
|
Apr 4 |
Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
|
Apr 2 |
Insiders Are Buying These 11 Penny Stocks
|
Apr 2 |
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
|
Jan 10 |
Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
|
Dec 11 |
EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year
|
Dec 11 |
Alzamend gets FDA letter for initiating Phase IIA study of lithium therapeutic drug candidate
|
Dec 11 |
Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients
|
Nov 21 |
Alzamend stock tumbles 18% in wake of clinical study update
|
Nov 20 |
Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients
|